Target intelligence / Profile preview

Zinc finger protein 148 (ZNF148)

Target
ZNF148
Molecular classification
Transcription factor, Kruppel-like zinc finger protein, DNA-binding protein
01

Overview

Zinc finger protein 148 (ZNF148) is a transcription factor belonging to the Kruppel family of zinc finger DNA-binding proteins. It regulates transcription by either activating or repressing target genes involved in cell proliferation, apoptosis, and immune responses. ZNF148 is upregulated in aneurysm tissue and plays a key role in smooth muscle cell phenotype modulation, impacting diseases like AAA, cancer, vascular pathology, and developmental disorders. The protein interacts cooperatively with other transcription factors (e.g., NF-1) and binds to promoter regions of genes controlling cell fate and inflammatory responses, making it a relevant therapeutic target for certain pathologies.

Other names
ZNF148ZBP89ZBP-89BERF-1BFCOL1HT-BETAZFP148pHZ-52transcription factor ZBP-89zinc finger DNA-binding protein 89CACCC box-binding proteinCLL-associated antigen KW-10GDACCF
02

Mechanism of action

Regulates gene expression by binding to G-rich boxes in enhancer regions and modulates transcription activation/repression; impacts cell proliferation and apoptosis partly through binding to promoters such as BAK and p21

03

Biological functions

Transcriptional regulationrepression and activation of specific genessmooth muscle cell phenotype modulationregulation of cell proliferationapoptosisimmune response modulation
04

Disease associations

Cancer (e.g., colorectal cancer)global developmental delayabsent or hypoplastic corpus callosumdysmorphic faciesaneurysm disease (AAA)vascular diseaseinfection (e.g., inhibition of HBV replication)
05

Safety considerations

Therapeutic targeting may potentially impact normal transcription regulation across multiple cell types, affecting proliferation, apoptosis, and immune response
06

Biomarkers

Increased expression correlates with decreased survival in colorectal cancer and increased AAA riskmutations relate to developmental delay

Beyond the preview

Go deeper on Zinc finger protein 148 (ZNF148).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger protein 148 (ZNF148).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call